Most Second-Line Lymphoma Patients Miss Curative Therapy
The LEO CReWE study analyzed 1,504 patients with relapsed or refractory large B-cell lymphoma treated from 2002 through 2022. Although autologous transplantation or CAR-T was planned for 65% at second line, only 31% received…
